IN8bio, Inc. (NASDAQ:INAB – Free Report) – Investment analysts at HC Wainwright raised their FY2029 earnings per share (EPS) estimates for shares of IN8bio in a report issued on Friday, August 7th. HC Wainwright analyst S. Ramakanth now expects that the company will post earnings of $0.32 per share for the year, up from their […]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | HC Wainwright Weighs in on Nuvation Bio Q1 Earnings | 0 | 9.79 | 10-08-2026 |
| 2 | HC Wainwright Forecasts Higher Earnings for Biomea Fusion | 0 | 9.98 | 10-08-2026 |
| 3 | HC Wainwright Has Optimistic Outlook of TNYA FY2026 Earnings | 0 | 11.9 | 10-08-2026 |
| 4 | FY2029 Earnings Estimate for AMLX Issued By HC Wainwright | 0 | 11.9 | 10-08-2026 |
| 5 | HC Wainwright Issues Pessimistic Outlook for SABS Earnings | 0 | 12.58 | 10-08-2026 |
| 6 | Energy Fuels FY2026 EPS Estimate Reduced by HC Wainwright | 0 | 13.4 | 10-08-2026 |
| 7 | HC Wainwright Has Weak Forecast for Cytosorbents Q1 Earnings | 0 | 11.13 | 10-08-2026 |
| 8 | HC Wainwright Weighs in on Delcath Systems Q1 Earnings | 0 | 10.45 | 10-08-2026 |
| 9 | FY2027 Earnings Forecast for Ardelyx Issued By HC Wainwright | 0 | 13.4 | 10-08-2026 |
| 10 | Q3 EPS Estimate for SAB Biotherapeutics Boosted by Analyst | 0 | 11.83 | 10-08-2026 |